Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Clinical trial NCT01162031 · WITHDRAWN
Trial details
- NCT number
- NCT01162031
- Sponsor
- Stanford University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.